Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 4, 2007, Pages 463-471

  Groeneveld, Peter W ^a,b,c   Matta, Mary A ^b   Suh, Janice J ^b   Yang, Feifei ^b   Shea, Judy A ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c 1229 Blockley Hall ^*  (United States)

Author keywords

Defibrillators; Implantable; Quality of life

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; DRIVING ABILITY; FEMALE; HEALTH CARE SYSTEM; HEART ELECTROPHYSIOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIMARY PREVENTION; RATING SCALE; RECIPIENT; SECONDARY PREVENTION; SEXUAL BEHAVIOR; SUDDEN DEATH; TREATMENT OUTCOME; VALIDITY;

AGED; COMORBIDITY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; PRIMARY PREVENTION; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 34247148095     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00694.x     Document Type: Article

References (32)

1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer OL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-237.
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883.
3. Implantable Cardioverter Defibrillator Implantation Data 2005-2006. Available at http://www.cms.hhs.gov/NonIdentifiableData Files/10. ICDImplantationData.asp#TopOfPage, Accessed August 2, 2006.
4. Ahmad M, Bloomstein L, Roelke M, Bernstein AD, Parsonnet V. Patients' attitudes toward implanted defibrillator shocks. Pacing Clin Electrophysiol 2000; 23:934-938.
5. Godemann F, Butter C, Lampe F, Linden M, Werner S, Behrens S. Determinants of the quality of life (QoL) in patients with an implantable cardioverter/defibrillator (ICD). Qual Life Res 2004; 13:411-416.
6. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, Newman D, et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002; 144:282-289.
7. Linde C. Quality-of-life in pacemaker and implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol 2000; 23:931-933.
8. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105:589-594.
9. Sears SF Jr, Conti JB. Quality of life and psychological functioning of ICD patients. Heart 2002; 87:488-493.
10. Burns JL, Serber ER, Keim S, Sears SF. Measuring patient acceptance of implantable cardiac device therapy: Initial psychometric investigation of the Florida Patient Acceptance Survey. J Cardiovasc Electrophysiol 2005; 16:384-390.
11. Groeneveld PW, Matta MA, Suh JJ, Heidenreich PA, Shea JA. Costs and quality-of-life effects of implantable cardioverter-defibrillators. Am J Cardiol 2006; 98:1409-1415.
12. McClellan MB, Tunis SR. Medicare coverage of ICDs. N Engl J Med 2005; 352:222-224.
13. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005; 353:1471-1480.
14. Al-Khatib SM, Anstrom KJ, Eisenstein EL, Peterson ED, Jollis JG, Mark DB, Li Y, et al. Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med 2005; 142:593-600.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40:373-383.
16. Hanmer J, Lawrence WF, Anderson JP, Kaplan RM, Fryback DG. Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Making 2006; 26:391-400.
17. Rabin R, de Charro F. EQ-5D: A measure of health status from the EuroQol Group. Ann Med 2001; 33:337-343.
18. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI(R)): Concepts, measurement properties and applications. Health Qual Life Outcomes 2003; 1:54.
19. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34:220-233.
20. Quality Metric Incorporated. The SF-12: An even shorter health survey. Available at: http://www.sf-36.org/tools/sf12.shtml. Accessed November 3, 2006.
21. Sears SF, Lewis TS, Kuhl EA, Conti JB. Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosomatics 2005; 46:451-457.
22. McCullagh P, Nelder JA. Generalized Linear Models, 2nd Ed. Boca Raton, Chapman & Hall/CRC, 1998.
23. Hamilton GA, Carroll DL. The effects of age on quality of life in implantable cardioverter defibrillator recipients. J Clin Nurs 2004; 13:194-200.
24. Hegel MT, Griegel LE, Black C, Goulden L, Ozahowski T. Anxiety and depression in patients receiving implanted cardioverter-defibrillators: A longitudinal investigation. Int J Psychiatry Med 1997; 27:57-69.
25. Heller SS, Ormont MA, Lidagoster L, Sciacca RR, Steinberg S. Psychosocial outcome after ICD implantation: A current perspective. Pacing Clin Electrophysiol 1998; 21:1207-1215.
26. Pauli P, Wiedemann G, Dengler W, Blaumann-Benninghoff G, Kuhlkamp V. Anxiety in patients with an automatic implantable cardioverter defibrillator: What differentiates them from panic patients? Psychosom Med 1999; 61:69-76.
27. Pelletier D, Gallagher R, Mitten-Lewis S, McKinley S, Squire J. Australian implantable cardiac defibrillator recipients: Quality-of-life issues. Int J Nurs Pract 2002; 8:68-74.
28. Schuster PM, Phillips S, Dillon DL, Tomich PL. The psychosocial and physiological experiences of patients with an implantable cardioverter defibrillator. Rehabil Nurs 1998; 23:30-37.
29. Epstein AE, Miles WM, Benditt DG, Camm AJ, Darling EJ, Friedman PL, Garson A Jr, et al. Personal and public safety issues related to arrhythmias that may affect consciousness: Implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology. Circulation 1996; 94:1147-1166.
30. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352:1539-1549.
31. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: Results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 2005; 111:2898-2905.
32. Groeneveld PW, Sonnad SS, Lee AK, Asch DA, Shea JA. Racial differences in attitudes toward innovative medical technology. J Gen Intern Med 2006; 21:559-563.